Article Versions Notes

Aparicio C, Queipo M, Belver M, Espeso F, Serna-Pérez J, Enríquez-Rodríguez L, Acebal C, Martín-Muñoz Á, Valeri A, Leivas A, et al. A Novel Early Memory-Enriched Allogeneic NKG2D CAR-T Cell Therapy Based on CRISPR/Cas9 Technology for Solid Tumors. Cancers. 2025; 17(19):3186. https://doi.org/10.3390/cancers17193186

Aparicio, Cristina, Mónica Queipo, Marina Belver, Francisco Espeso, Julia Serna-Pérez, Lucía Enríquez-Rodríguez, Carlos Acebal, Álvaro Martín-Muñoz, Antonio Valeri, Alejandra Leivas, and et al. 2025. "A Novel Early Memory-Enriched Allogeneic NKG2D CAR-T Cell Therapy Based on CRISPR/Cas9 Technology for Solid Tumors" Cancers 17, no. 19: 3186. https://doi.org/10.3390/cancers17193186

Aparicio, C., Queipo, M., Belver, M., Espeso, F., Serna-Pérez, J., Enríquez-Rodríguez, L., Acebal, C., Martín-Muñoz, Á., Valeri, A., Leivas, A., Río, P., Powell, D. J., Jr., Lobo-Valentín, R., Arrabal, D., Martínez-López, J., Sánchez, A., de la Fuente, M. Á., & González-Vallinas, M. (2025). A Novel Early Memory-Enriched Allogeneic NKG2D CAR-T Cell Therapy Based on CRISPR/Cas9 Technology for Solid Tumors. Cancers, 17(19), 3186. https://doi.org/10.3390/cancers17193186